Research compound profile
GHK-Cu
Copper peptide · Gly–His–Lys : Cu(II) — extracellular matrix research context
GHK-Cu is described in the literature as a copper-binding tripeptide (glycine–histidine–lysine coordinated with Cu(II)) studied in wound-repair, matrix biology, and related in vitro / preclinical models. Some reports discuss circulating peptide levels by age in small cohorts—interpretation belongs in qualified research review, not consumer marketing. NEXT lists materials for authorized research use only—not for human cosmetics claims, clinical treatment, or veterinary therapy.
Compound specifications
Mechanism — research framing
- Copper delivery context: Literature explores Cu(II) handling in enzyme systems relevant to redox and matrix biochemistry in model systems.
- ECM remodeling narratives: Preclinical work discusses collagen and protease balance readouts—not guaranteed outcomes for purchased materials.
- Growth-factor–adjacent signaling: Some reports tie peptide exposure to angiogenesis or fibroblast assays under controlled conditions; replication and IRB context matter.
- Transcript-level claims: Broad gene-expression hypotheses appear in specialized papers; treat as research-only, not a catalog claim.
- Oxidative stress models: Antioxidant framing is discussed in cell assays—does not establish human benefit here.
Areas of research interest (literature)
- Wound and barrier models — endpoints depend on protocol; not predictive for buyers.
- Dermal matrix and elasticity readouts — investigational instrumentation and cohort design vary widely.
- Hair follicle biology — research context only; not a treatment claim.
- Nerve repair and organotypic models — qualified laboratory discussion.
- Pulmonary fibrosis / remodeling narratives — regulatory path is compound- and region-specific.
- Aging-biology plasma peptide discussions — population statistics are not individualized guidance.
Peptide regulations & site policy
- RUO: Materials are sold for research use only. They are not drugs, supplements, or cosmetics for human or animal use unless your program holds all required authorizations.
- FDA / FTC: Investigational compounds are not FDA-approved for the uses discussed in lay media. This page is educational; it does not diagnose, treat, cure, or prevent any disease.
- No clinical instructions: NEXT does not provide dosing, reconstitution for injection in humans, cycle advice, or prescribing information.
- Jurisdiction: Import, possession, and use of research peptides are regulated differently by country and state. You are responsible for lawful conduct in your location.
- COA & chain of custody: Batch documentation is provided per catalog policy; storage, handling, and record-keeping are your laboratory’s responsibility.
- Wholesale / retail paths: Volume and institutional purchasing follow B2B membership rules after approval; retail checkout follows discount membership and storefront terms.